A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol.

نویسندگان

  • Marco Mancini
  • Daniela Scappaticci
  • Giuseppe Cimino
  • Mauro Nanni
  • Valentina Derme
  • Loredana Elia
  • Agostino Tafuri
  • Marco Vignetti
  • Antonella Vitale
  • Antonio Cuneo
  • Gianluigi Castoldi
  • Giuseppe Saglio
  • Fabrizio Pane
  • Cristina Mecucci
  • Andrea Camera
  • Giorgina Specchia
  • Alessandra Tedeschi
  • Francesco Di Raimondo
  • Giuseppe Fioritoni
  • Francesco Fabbiano
  • Filippo Marmont
  • Felicetto Ferrara
  • Nicola Cascavilla
  • Giuseppe Todeschini
  • Francesco Nobile
  • Maria Grazia Kropp
  • Pietro Leoni
  • Antonio Tabilio
  • Mario Luppi
  • Luciana Annino
  • Franco Mandelli
  • Robin Foà
چکیده

The Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) 0496 protocol, through the central handling of bone marrow samples at presentation, allowed us to combine cytogenetic and molecular information on a large series of adults with acute lymphoblastic leukemia (ALL) treated homogeneously, enabling us to define as broadly as possible their genetic profile and to determine the impact on outcome of the cytogenetic-molecular signature. Of 414 patients centrally processed, 325 were considered for the categorization into the following cytogenetic-molecular subgroups: normal, t(9;22)/BCR-ABL, t(4;11)/MLL-AF4, t(1;19)/E2A-PBX1, 9p/p15-p16 deletions, 6q deletions, miscellaneous structural abnormalities, and hyperdiploid. The inclusion into each subgroup was based on a hierarchical approach: molecular abnormalities with adverse prognosis had precedence over karyotypic changes with less-defined prognosis and the latter over ploidy. Patients without abnormalities and those with isolated 9p/p15-p16 deletions showed a relatively favorable outcome (median disease-free survival [DFS], > 3 years). The t(9;22)/BCR-ABL, t(4;11)/MLL-AF4, t(1; 19)/E2A-PBX1 defined a group with dismal prognosis (median DFS, 7 months), whereas 6q deletions, miscellaneous aberrations, and hyperdiploidy predicted an intermediate prognosis (median DFS, 19 months). This study highlights the importance of a combined cytogenetic-molecular profiling of adult ALL at presentation as a critical independent determinant of their outcome, providing further evidence of the necessity of a risk-adapted therapeutic algorithm for an optimal management of these patients.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol

Marco Mancini, Daniela Scappaticci, Giuseppe Cimino, Mauro Nanni, Valentina Derme, Loredana Elia, Agostino Tafuri, Marco Vignetti, Antonella Vitale, Antonio Cuneo, Gianluigi Castoldi, Giuseppe Saglio, Fabrizio Pane, Cristina Mecucci, Andrea Camera, Giorgina Specchia, Alessandra Tedeschi, Francesco Di Raimondo, Giuseppe Fioritoni, Francesco Fabbiano, Filippo Marmont, Felicetto Ferrara, Nicola Ca...

متن کامل

Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial.

BACKGROUND AND OBJECTIVES The prognostic value of myeloid antigen (MyAg) expression in adult acute lymphoblastic leukemia (ALL) is still controversial. The aim of this study was to correlate the expression of MyAg with clinical, hematologic and biological parameters, and to analyze the impact on response to treatment and prognosis in a large series of adult ALL uniformly characterized and treat...

متن کامل

CLINICAL TRIALS AND OBSERVATIONS Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol

Between 1996 and 2000, 90 newly diagnosed adult patients with T-acute lymphoblastic leukemia (T-ALL) were registered in the Gruppo Italiano Malattie Ematologiche dell’Adulto (GIMEMA) Leucemia Acuta Limfoide (LAL) 0496 protocol. Cases were centrally processed for morphology, immunophenotype, cytogenetics, molecular biology, and multidrug resistance (MDR). Twenty-two patients were females and 68 ...

متن کامل

Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol.

Between 1996 and 2000, 90 newly diagnosed adult patients with T-acute lymphoblastic leukemia (T-ALL) were registered in the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Leucemia Acuta Limfoide (LAL) 0496 protocol. Cases were centrally processed for morphology, immunophenotype, cytogenetics, molecular biology, and multidrug resistance (MDR). Twenty-two patients were females and 68 ...

متن کامل

Influences of Genetic Abnormality on the Risk of Acute Lymphoblastic Leukemia

Recent studies have provided evidence that common genetic variations could account for a proportion of leukemia in adult or children. To evaluate the contribution of candidate gene association studies to the understanding of genetic susceptibility to acute lymphoblastic leukemia we conducted a systematic review from published studies. The polymorphisms of genes encoding carcinogen-metabolizi...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Blood

دوره 105 9  شماره 

صفحات  -

تاریخ انتشار 2005